Healthcare & Medical Devices Global On demand · 24-48h

Global Laboratory Lateral Flow Assays Market Strategic Research Report

Global Laboratory Lateral Flow Assays Market Strategic Resea…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Laboratory Lateral Flow Assays Market
$9002025
7.2%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Urine Testing, Saliva Testing, Blood Testing, Other

By Application: Infectious Disease Testing, Biomarker Screening, Food & Environmental Safety Testing, Veterinary Diagnostics, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Abbott Laboratories, Becton, Dickinson and Company, Biomérieux, Bio-Rad Laboratories, Danaher Corporation, F Hoffmann-La Roche, Merck, Quidel Corporation, Siemens Healthineers, Thermo Fisher Scientific

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 100 pages
Market size 2025
$900
Million USD
Forecast CAGR
7.2%
2025-2032
Forecast 2032
$1464.2
Projected
Regionen
5
Asia Pacific · Latin America · MEA · Europe · North America

Übersicht

Scope of the Report

The global Laboratory Lateral Flow Assays market size is predicted to grow from US$ 900 million in 2025 to US$ 1,457 million in 2032; it is expected to grow at a CAGR of 7.2% from 2026 to 2032.

The laboratory lateral flow assays market is driven by increasing demand for rapid, cost-effective diagnostic solutions in clinical and research laboratories. These assays offer fast turnaround times and simplified workflows compared with traditional laboratory methods. Growth is supported by expanding infectious disease testing, biomarker screening, and decentralized diagnostic models. Advances in antibody engineering and assay sensitivity further enhance performance. Overall, the market is expected to grow steadily as laboratories seek efficient testing tools that balance speed, accuracy, and cost.

The gross profit margin of major companies in the industry is between 50%–70%.

Laboratory Lateral Flow Assays are rapid diagnostic testing methods based on immunochromatographic principles, enabling qualitative or semi-quantitative detection of specific analytes in biological samples. These assays provide fast results, ease of operation, and reliable performance, making them suitable for laboratory diagnostics, screening, and research applications.

The industrial chain of Laboratory Lateral Flow Assays includes upstream components such as antibodies, antigens, nitrocellulose membranes, sample pads, conjugate pads, labels, and reagents. The midstream focuses on strip assembly, reagent deposition, drying, cutting, and packaging. Downstream applications cover clinical laboratories, research institutions, diagnostic service providers, and quality control laboratories, supported by validation, distribution, and technical support services.

This report presents a comprehensive overview of the global Laboratory Lateral Flow Assays market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Urine Testing
  • Saliva Testing
  • Blood Testing
  • Other

Segment by Labeling Technology

  • Sandwich Assay Format
  • Competitive Assay Format
  • Multiplex Assay Format

Segment by Application

  • Infectious Disease Testing
  • Biomarker Screening
  • Food & Environmental Safety Testing
  • Veterinary Diagnostics
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Laboratory Lateral Flow Assays market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Infectious Disease Testing, Biomarker Screening, Food & Environmental Safety Testing evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Laboratory Lateral Flow Assays Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.2%
Regional growth momentum
Market share by segment
Key metrics
Base value
$900
2025
Forecast
$1464.2
2032
CAGR
7.2%
2025–2032
Regionen
5
global
Key companies
Abbott LaboratoriesBectonDickinson and CompanyBiomérieuxBio-Rad LaboratoriesDanaher CorporationF Hoffmann-La RocheMerck
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Urine TestingSaliva TestingBlood TestingOther
By Application
Infectious Disease TestingBiomarker ScreeningFood & Environmental Safety TestingVeterinary DiagnosticsOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Urine Testing
  • 3.1.3 Saliva Testing
  • 3.1.4 Blood Testing
  • 3.1.5 Other
  • 3.1.6 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Infectious Disease Testing
  • 4.1.3 Biomarker Screening
  • 4.1.4 Food & Environmental Safety Testing
  • 4.1.5 Veterinary Diagnostics
  • 4.1.6 Other
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Abbott Laboratories
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Becton, Dickinson and Company
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Biomérieux
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Bio-Rad Laboratories
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Danaher Corporation
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 F Hoffmann-La Roche
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Merck
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Quidel Corporation
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Siemens Healthineers
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Thermo Fisher Scientific
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Laboratory Lateral Flow Assays market?
The global Laboratory Lateral Flow Assays market is estimated at US$ 900 million in 2025 (base year) and is projected to reach US$ 1.46 billion by 2032.
What is the forecast CAGR for the Laboratory Lateral Flow Assays market?
The market is expected to grow at a CAGR of 7.2% from 2026 to 2032, expanding from US$ 900 million in 2025 to US$ 1.46 billion in 2032, roughly 1.6 times its base-year value.
What is Laboratory Lateral Flow Assays?
The laboratory lateral flow assays market is driven by increasing demand for rapid, cost-effective diagnostic solutions in clinical and research laboratories. These assays offer fast turnaround times and simplified workflows compared with traditional laboratory methods. Growth is supported by expanding infectious disease testing, biomarker screening, and decentralized diagnostic models.
How is the Laboratory Lateral Flow Assays market segmented by type?
By type, the market is segmented into Urine Testing, Saliva Testing, Blood Testing and Other.
What are the key applications of Laboratory Lateral Flow Assays?
Key applications covered include Infectious Disease Testing, Biomarker Screening, Food & Environmental Safety Testing, Veterinary Diagnostics and Other.
Which companies are profiled in the Laboratory Lateral Flow Assays market report?
Key players profiled include Abbott Laboratories, Becton, Dickinson and Company, Biomérieux, Bio-Rad Laboratories, Danaher Corporation, F Hoffmann-La Roche, Merck and Quidel Corporation, among 10 companies covered in total.
What geographies does the Laboratory Lateral Flow Assays market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Laboratory Lateral Flow Assays?
Downstream applications cover clinical laboratories, research institutions, diagnostic service providers, and quality control laboratories, supported by validation, distribution, and technical support services.
Who should buy the Laboratory Lateral Flow Assays market report?
The report is intended for manufacturers and solution providers, distributors and end users in Infectious Disease Testing, Biomarker Screening and Food & Environmental Safety Testing, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Laboratory Lateral Flow Assays market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from 3.500,00 $
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.